Article Notes
Article pearls, summaries and comments.
The monoclonal antibody-fragment idarucizumab reliably reverses the thrombin-inhibitor anticoagulant dabigatran ('Pradaxa') within minutes of administration.
Daniel Jolley
Keep up to date with a free trial of metajournal, personalized for your practice.
1,624,503 articles already indexed!